Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Short term Debt (2020 - 2025)

PROCEPT BioRobotics has reported Short term Debt over the past 4 years, most recently at $2.0 million for Q1 2025.

  • Quarterly Short term Debt rose 4.49% to $2.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Mar 2025, up 4.49% year-over-year, with the annual reading at $2.0 million for FY2024, 6.04% up from the prior year.
  • Short term Debt was $2.0 million for Q1 2025 at PROCEPT BioRobotics, roughly flat from $2.0 million in the prior quarter.
  • Over five years, Short term Debt peaked at $2.0 million in Q3 2024 and troughed at $1.9 million in Q4 2023.
  • The 3-year median for Short term Debt is $2.0 million (2024), against an average of $2.0 million.
  • Year-over-year, Short term Debt increased 6.04% in 2024 and then rose 4.49% in 2025.
  • A 3-year view of Short term Debt shows it stood at $1.9 million in 2023, then increased by 6.04% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Short term Debt are $2.0 million (Q1 2025), $2.0 million (Q4 2024), and $2.0 million (Q3 2024).